Introduction to the Inflation Reduction Act
ADVI Experts Lindsay Bealor Greenleaf and Brenna Raines discuss prescription drug pricing following the Inflation Reduction Act (IRA). Hear about key developments in 2023, starting with insights into how drugs will be targeted for government-negotiated pricing.
In 2023, we are watching the market reaction. What are the Part D plans doing now as they prepare for the changes coming in 2025 when they are on the hook for a greater percentage of spending on Part D benefit.
Full Transcript
We look forward to hearing from you and discussing how these issues are relevant to your business needs.
Stay ahead of the curve. Get in touch today to gain expert insights into the IRA and the evolving healthcare landscape.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.